Small-volume resuscitation: from experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions.
about
The Toronto prehospital hypertonic resuscitation-head injury and multi organ dysfunction trial (TOPHR HIT)--methods and data collection tools.The role of pre-hospital blood gas analysis in trauma resuscitationEarly fluid resuscitation with hyperoncotic hydroxyethyl starch 200/0.5 (10%) in severe burn injury.In vitro impairment of whole blood coagulation and platelet function by hypertonic saline hydroxyethyl starch.Hypertonic saline reduces vascular leakage in a mouse model of severe dengue.Mechanotransduction and the homeostatic significance of maintaining blood viscosity in hypotension, hypertension and haemorrhage.Hypertonic saline reduces neutrophil-epithelial interactions in vitro and gut tissue damage in a mouse model of colitisOxidative stress decreases phosphatidylinositol 4,5-bisphosphate levels by deactivating phosphatidylinositol- 4-phosphate 5-kinase beta in a Syk-dependent manner.Effects of hypertonic (7%) saline on brain injury in experimental Escherichia coli meningitis.Evaluation of the clinical effect of small-volume resuscitation on uncontrolled hemorrhagic shock in emergency.Influence of prehospital fluid resuscitation on patients with multiple injuries in hemorrhagic shock in patients from the DGU trauma registry.Plasma hyperosmolality improves tolerance to combined heat stress and central hypovolemia in humans.Prehospital fluid management of abdominal organ trauma patients--a matched pair analysis.Effect of hypertonic saline on hypotension following induction of general anesthesia: A randomized controlled trial.Neurohypophyseal response to fluid resuscitation with hypertonic saline during septic shock in rats.Intravenous infusion of hyperosmotic NaCl solution induces acute cor pulmonale in anesthetized rats.Hemodynamic effects of volume replacement with saline solution and hypertonic hydroxyethyl starch in dogs.Hypertonic saline solutions attenuate agonist-induced changes of intracellular calcium.Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: a prospective clinical trial in critically ill patients with subarachnoid haemorrhage.Hypertonic saline and hemorrhagic shock: hepatocellular function and integrity after six hours of treatment.Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia.Combinatorial therapy with two pro-coagulants and one osmotic agent reduces the extent of the lesion in the acute phase of spinal cord injury in the rat.Hibernation-based blood loss therapy increases survivability of lethal hemorrhagic shock in rats.Comparison of the in vitro effects of saline, hypertonic hydroxyethyl starch, hypertonic saline, and two forms of hydroxyethyl starch on whole blood coagulation and platelet function in dogs.Reduced fluid gain during cardiopulmonary bypass in piglets using a continuous infusion of a hyperosmolar/hyperoncotic solution.Effects of hyperoncotic or hypertonic-hyperoncotic solutions on polymorphonuclear neutrophil count, elastase- and superoxide-anion production: a randomized controlled clinical trial in patients undergoing elective coronary artery bypass grafting.Acid base and electrolyte changes after hypertonic saline (7.5%) infusion: a randomized controlled clinical trial.
P2860
Q33516402-AB488E61-6DD0-4938-AF2A-D1509984237AQ33863535-3A733BEC-9041-4951-8A09-E6AA813886ABQ34027076-962E7F2B-BF1B-4799-9BED-11140ADAAEAEQ34607991-FFF5AFB1-C2E7-4522-9776-4E679F77A5E9Q34700472-C3AA73B3-6684-4488-8BE5-5ED0B33D3DD6Q36440496-89E5493F-44EF-4037-A2C6-AFD36556C249Q37200063-361A978A-50FF-43CC-9973-EECD71DEE74AQ37358192-89A3E919-6FA4-4534-9EAE-827B8739CBA3Q37425727-CB42785C-1FCA-4E5B-901E-FF9B47F9525EQ37732384-2B962CA8-A896-4B9D-997A-30A2588689BBQ39054791-4AC734EE-743F-4450-9ACD-85E35BBD9885Q39076939-4B5C2902-C6B4-4AD4-81A9-3CD6D4306782Q41437255-C250EBF5-C08A-4377-AE45-C483977640E3Q42882456-A4F123F9-7F98-457B-BC70-5F4939F48A41Q44039020-03C82D4D-DC42-4DA1-B1E4-7CADC48CA702Q44204755-57907A93-DCA9-4DD5-B67A-EBA7774E0F8CQ44427027-CD778464-467D-4E47-B7A9-3D05C8370E9FQ44777252-3999B952-E672-47A4-A7D4-47E37F726B61Q45048402-BB38C42F-928F-4CEE-BBEA-ABEB680CEBB6Q46815373-3663D53D-8DCC-44CA-B17D-D9DF5E323155Q47105849-7975A28F-BE30-4C32-BFB1-31EC2BA5C3FCQ47144332-B4934C3C-07D7-400A-AF5A-55A3ABBE761AQ48097088-DD9D3073-6CDF-4AD9-AD1B-903407527E65Q48179938-0EDC3B0A-E2CF-46A3-A67B-5DE1024CDB4BQ48458598-4BAB812A-94B6-4B7F-B5E3-7CAAF1C39195Q48589577-8BC3E795-8A92-470B-AAD9-97F97F1487B2Q51227428-C71C4726-2DAE-4BD6-998A-7B24359FF10D
P2860
Small-volume resuscitation: from experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Small-volume resuscitation: fr ...... tages of hypertonic solutions.
@ast
Small-volume resuscitation: fr ...... tages of hypertonic solutions.
@en
Small-volume resuscitation: fr ...... tages of hypertonic solutions.
@nl
type
label
Small-volume resuscitation: fr ...... tages of hypertonic solutions.
@ast
Small-volume resuscitation: fr ...... tages of hypertonic solutions.
@en
Small-volume resuscitation: fr ...... tages of hypertonic solutions.
@nl
prefLabel
Small-volume resuscitation: fr ...... tages of hypertonic solutions.
@ast
Small-volume resuscitation: fr ...... tages of hypertonic solutions.
@en
Small-volume resuscitation: fr ...... tages of hypertonic solutions.
@nl
P2860
P1476
Small-volume resuscitation: fr ...... tages of hypertonic solutions.
@en
P2093
Uwe Kreimeier
P2860
P304
P356
10.1034/J.1399-6576.2002.460601.X
P407
P577
2002-07-01T00:00:00Z